Clinical trial
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00333151
Study timeline
Study start (unknown)2006-05-01Date precision: month
Registry last updated2017-01-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Diabetes Mellitus, Type 2unresolved
Interventions
liraglutideDRUG · verified · RxNorm: liraglutide
rosiglitazoneDRUG · verified · RxNorm: rosiglitazone
metforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
DallasTexas, United States4AtlantaGeorgia, United States3HoustonTexas, United States2Los AngelesCalifornia, United States2San AntonioTexas, United States2ColumbusOhio, United States2St LouisMissouri, United States1TorontoOntario, Canada1ClevelandOhio, United States1CincinnatiOhio, United States1DurhamNorth Carolina, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00333151 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.